Navigation Links
Hope For Stiff-Person Syndrome

At present, there is no cure for stiff-person syndrome, a disease marked by high levels of antibodies to glutamic acid decarboxylase (GAD65), an enzyme involved in the production of a movement-regulating neurotransmitter.// Patients are usually treated with Valium (diazepam), which is only mildly successful at controlling symptoms. While the cause of stiff-person syndrome is unknown, doctors had suspected that it may be an autoimmune disorder.

About 1 in every million people has the disorder, though it is often misdiagnosed and may be more common than recognized. Up to 65% of patients cannot perform daily tasks because of total-body stiffness or frequent falls. Some patients rely on walkers or wheelchairs while others are completely bedridden. Exposure to noise, touch or emotional distress can set off muscle spasms, and some patients are afraid to leave their house because of the spasms.

High doses of antibodies may help relieve the muscle rigidity and spasms associated with stiff-person syndrome. Patients who had infusions of immune globulin - a collection of antibodies derived from donor blood for 3 months were able to walk more easily, fell down less often, and reported improvements in their ability to perform work-related and household tasks.

The Findings indicate that intravenous immune globulin is safe, well tolerated, and effective for stiff-person syndrome and significantly improves patients' ability to perform the activities of daily living and thus, their quality of life. While the treatment had no major side effects, it is expensive, costing more than $10,000 a month.
'"/>




Page: 1

Related medicine news :

1. Early Clue to Down Syndrome
2. Restless Legs Syndrome - Help at hand
3. Severe Acute respiratory Syndrome (SARS)
4. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
5. Treatment for Syndrome X
6. “ Economy Class Syndrome
7. Dementia and Down Syndrome
8. Understanding Restless Legs Syndrome
9. A New Option for Patients Suffering From QT Syndrome
10. Individuals With Metabolic Syndrome At Risk of Dying From Heart Disease
11. The Link Between Pregnancy and Restless Legs Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... the year of enhancements, upgrading their training and leads programs. , In February, ... Reserved for elite sales agents, Performance Partners is designed to teach how to ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming ... the creation of published author, Wesley Gerboth, a World War II veteran, with a ... Now, at age ninety-one, he shares the Wisdom God bestowed upon him in this ...
(Date:3/24/2017)... ... ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous ... the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks at ... her passion for writing, especially about truth and human behavior. , Published by Christian ...
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF ... the greater Houston Area. The new location is located at 2255 E. Mossy Oaks ... Springwoods Village. This newest location will provide patients living in the north Houston area ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... City Convention Center at 10 North Broadway Avenue, will be an educational and ... relevant, practical instruction in the management of chronic pain. , Oklahoma is in ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017  Eli Lilly and Company (NYSE: ... $850 million in its U.S. operations in 2017. ... enterprise, including research laboratories, manufacturing sites, and general ... by demand for Lilly products, as well as ... targeting cancer, pain, diabetes and other unmet medical ...
(Date:3/24/2017)... GENEVA , March 24, 2017 /PRNewswire/ ... Day revitalizes efforts to develop sutezolid as effective response ... Tuberculosis Day, TB Alliance and the Medicines Patent Pool ... of sutezolid, an antibiotic drug candidate which demonstrated encouraging ... development of sutezolid in combination with other TB drugs ...
(Date:3/23/2017)... The key factors driving the growth of dialysis ... growth and increasing healthcare expenditure. Some of the noteworthy trends ... ESRD patients, rising demand for home PD treatment and huge ... market is hindered by high treatment costs and stringent regulations. ... Complete ...
Breaking Medicine Technology: